CPA
AMPH icon

Court Place Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Court Place Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,500
Closed -$267K – 150
2024
Q3 		$267K Hold
5,500
– – 0.08% 143
2024
Q2 		$220K Buy
+5,500
New +$228K 0.07% 151
2024
Q1 		– Sell
-5,500
Closed -$340K – 155
2023
Q4 		$340K Buy
+5,500
New +$289K 0.11% 123

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Court Place Advisors's AMPH Position: Q4 2024 in Review

Court Place Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 5,500 shares — an estimated $267K sold.

Court Place Advisors first reported a position in AMPH in Q4 2023 and held it in 3 quarters. The position peaked at $340K in Q4 2023. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • Court Place Advisors reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Court Place Advisors sold 5,500 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $267K.
  • Court Place Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Court Place Advisors's Amphastar Pharmaceuticals position peaked at $340K in Q4 2023.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Court Place Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.